"Antineoplastic therapy" OR "Antineoplastic agent"
Showing 1 - 25 of >10,000
Non-Hodgkin Lymphoma, Diffuse Large B Cell Lymphoma, Follicular Lymphoma, Mantle Cell Lymphoma, Marginal Zone Lymphoma Trial in
Recruiting
- Non-Hodgkin Lymphoma, Diffuse Large B Cell Lymphoma, Follicular Lymphoma, Mantle Cell Lymphoma, Marginal Zone Lymphoma
-
Columbus, Ohio
- +9 more
Aug 1, 2022
Atrial Fibrillation in Patients With Cancer (MAFIC Study)
Recruiting
- Cancer
- Atrial Fibrillation
- Low molecular weight heparin
-
Thessaloniki, Greece
- +1 more
Feb 14, 2022
Thiotepa and TEPA Drug Exposure in Pediatric Hematopoietic Stem
Active, not recruiting
- Hematologic Malignancies
- +7 more
-
San Francisco, CaliforniaUniversity of California, San Francisco
Feb 28, 2022
![](/image/sponsor/university_hospital_"sestre_milosrdnice")
Responsible Side Effects Management in Oncology
Completed
- Pharmacovigilance
- +2 more
-
Zagreb, Croatia, Europe, CroatiaUHC Sestre milorsdnice
Nov 4, 2020
Myelodysplastic Syndrome, Acute Myeloid Leukemia Trial in Tampa, Cleveland (Idarubicin, Cytarabine, Lenalidomide (Revlimid®))
Completed
- Myelodysplastic Syndrome
- Acute Myeloid Leukemia
- Idarubicin
- +2 more
-
Tampa, Florida
- +1 more
Dec 1, 2020
Reporting of AdVerse Events Associated With AnTicAncerRapy
Recruiting
- Cancer
- Antineoplastic and Immunomodulating Agents
-
Caen, Basse Normandie, FranceAlexandre Joachim
Jan 4, 2021
Advanced Solid Tumours, Actinium-225, Antineoplastic Agents Trial in Australia, Canada, United States ([111In]-FPI-1547
Recruiting
- Advanced Solid Tumours
- +4 more
- [111In]-FPI-1547 Injection
- +3 more
-
Duarte, California
- +12 more
Mar 2, 2022
Non Small Cell Lung Cancer, Solid Tumors, Adult, Endometrial Cancer Trial in Fairfax (TNG260, Pembrolizumab)
Recruiting
- Non Small Cell Lung Cancer
- +6 more
-
Fairfax, VirginiaNEXT Oncology
Jun 7, 2023
Drug-Induced Acute Liver Injury Trial in Tianjin (Bicyclol tablets)
Recruiting
- Drug-Induced Acute Liver Injury
- Bicyclol tablets
-
Tianjin, Tianjin, ChinaTianjin Medical University Cancer Institute & Hospital
Feb 2, 2023
Oral Mucositis (Ulcerative), Oral Mucositis (Ulcerative) Due to Radiation, Oral Mucositis (Ulcerative) Due to Antineoplastic
Recruiting
- Oral Mucositis (Ulcerative)
- +3 more
- Photobiomodulation
- Routine Oral Care and Analgesia
-
Birmingham, Alabama
- +6 more
Jan 18, 2022
COVID Trial in Vienna (Azithromycin 500 milligram (mg) oral Tablet, Placebo)
Completed
- COVID
- Azithromycin 500 milligram (mg) oral Tablet
- Placebo
-
Vienna, AustriaAKH Vienna, Department for Internal Medicine I, Oncology
Apr 6, 2022
Metastatic Prostate Cancer Trial (Darolutamide, Radium-223)
Not yet recruiting
- Metastatic Prostate Cancer
- (no location specified)
Mar 6, 2023
Pelvic Floor Disorders Trial in Wiesbaden
Recruiting
- Pelvic Floor Disorders
-
Wiesbaden, GermanySt. Josefs-Hospital Wiesbaden GmbH
Dec 3, 2020
Endometrial Cancer, Serous Adenocarcinoma, Uterine Tumor Trial (Niraparib oral capsule)
Not yet recruiting
- Endometrial Cancer
- +2 more
- Niraparib oral capsule
- (no location specified)
Oct 31, 2022
HER2 Positive Early Breast Cancer Trial in Shanghai (Docetaxel, carboplatin, Trastuzumab)
Recruiting
- HER2 Positive Early Breast Cancer
- Docetaxel
- +5 more
-
Shanghai, Shanghai, ChinaFudan University Shanghai Cancer Center Shanghai, China, 200032
Jun 6, 2023
Esophageal Squamous Cell Carcinoma, Gastric Adenocarcinoma, Gastroesophageal Junction Adenocarcinoma Trial in Multiple Locations
Recruiting
- Esophageal Squamous Cell Carcinoma
- +3 more
- Routine care as per site standard
-
Multiple Locations, GermanyMultiple sites, Gemany
Jun 3, 2022
Salivary Gland Cancer Trial (vedicitumomab (Edisil, RC48), vedicitumomab in combination with pyrrolizidine, RC48 in combination
Not yet recruiting
- Salivary Gland Cancer
- vedicitumomab (Edisil, RC48）
- +3 more
- (no location specified)
Jun 9, 2023
RET-altered Non Small Cell Lung Cancer, Medullary Thyroid Cancer, RET-altered Papillary Thyroid Cancer Trial in Worldwide
Active, not recruiting
- RET-altered Non Small Cell Lung Cancer
- +39 more
- pralsetinib (BLU-667)
-
Phoenix, Arizona
- +65 more
Nov 10, 2022
Non Small Cell Lung Cancer, Complete Surgical Resection, Circulating Tumor DNA Trial in Toronto (Nivolumab, Pemetrexed,
Recruiting
- Non Small Cell Lung Cancer
- +2 more
- Nivolumab
- +5 more
-
Toronto, Ontario, CanadaPrincess Margaret Cancer Centre
Apr 21, 2022
Breast Cancer Survivors, Postmenopause, Resistance Training Trial in Temuco (Prolonged resistance-type exercise training)
Not yet recruiting
- Breast Cancer Survivors
- +2 more
- Prolonged resistance-type exercise training
-
Temuco, ChileDepartment of Rehabilitation Sciences, Faculty of Medicine, Univ
Jan 9, 2023
